Prefrontal Pathways Provide Top-Down Control of Memory for Sequences of Events.
Animals
Clozapine
/ analogs & derivatives
GABA Antagonists
/ pharmacology
Hippocampus
/ physiology
Memory, Short-Term
/ drug effects
Midline Thalamic Nuclei
/ drug effects
Neural Pathways
/ physiology
Perirhinal Cortex
/ drug effects
Prefrontal Cortex
/ cytology
Rats
Rats, Long-Evans
Receptor, Muscarinic M4
/ drug effects
Serotonin Antagonists
/ pharmacology
DREADDs
cognitive control
episodic memory
hippocampus
memory retrieval
nucleus reuniens
perirhinal cortex
temporal context
thalamus
working memory
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
16 07 2019
16 07 2019
Historique:
received:
08
02
2019
revised:
19
05
2019
accepted:
14
06
2019
entrez:
18
7
2019
pubmed:
18
7
2019
medline:
28
8
2020
Statut:
ppublish
Résumé
We remember our lives as sequences of events, but it is unclear how these memories are controlled during retrieval. In rats, the medial prefrontal cortex (mPFC) is positioned to influence sequence memory through extensive top-down inputs to regions heavily interconnected with the hippocampus, notably the nucleus reuniens of the thalamus (RE) and perirhinal cortex (PER). Here, we used an hM4Di synaptic-silencing approach to test our hypothesis that specific mPFC→RE and mPFC→PER projections regulate sequence memory retrieval. First, we found non-overlapping populations of mPFC cells project to RE and PER. Second, suppressing mPFC activity impaired sequence memory. Third, inhibiting mPFC→RE and mPFC→PER pathways effectively abolished sequence memory. Finally, a sequential lag analysis showed that the mPFC→RE pathway contributes to a working memory retrieval strategy, whereas the mPFC→PER pathway supports a temporal context memory retrieval strategy. These findings demonstrate that mPFC→RE and mPFC→PER pathways serve as top-down mechanisms that control distinct sequence memory retrieval strategies.
Identifiants
pubmed: 31315044
pii: S2211-1247(19)30826-5
doi: 10.1016/j.celrep.2019.06.053
pmc: PMC6662648
mid: NIHMS1534954
pii:
doi:
Substances chimiques
GABA Antagonists
0
Receptor, Muscarinic M4
0
Serotonin Antagonists
0
Clozapine
J60AR2IKIC
clozapine N-oxide
MZA8BK588J
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
640-654.e6Subventions
Organisme : NINDS NIH HHS
ID : F99 NS119001
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH113626
Pays : United States
Informations de copyright
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.